Skip to main content
letter
. 2019 Sep 30;13(4):714–719. doi: 10.1093/ckj/sfz129

FIGURE 2.

FIGURE 2

RAASi use and HK treatment at HK1/HK2 in the 12-month observational period in the subgroups of patients with (A) HFrEF (n = 333) or (B) DN (n = 376). Significant difference from HK1, McNemar test: ***P < 0.001.